Edition:
United States

People: United Therapeutics Corp (UTHR.OQ)

UTHR.OQ on NASDAQ Stock Exchange Global Select Market

104.95USD
22 May 2018
Change (% chg)

$0.83 (+0.80%)
Prev Close
$104.12
Open
$104.09
Day's High
$105.15
Day's Low
$104.09
Volume
7,645
Avg. Vol
182,737
52-wk High
$152.55
52-wk Low
$100.64

Benkowitz, Michael 

Mr. Michael Benkowitz is President, Chief Operating Officer of the Company. He joined United Therapeutics in 2011 as Executive Vice President, Organizational Development. In this role, he was responsible for most companywide administrative functions, including human resources, information technology, corporate real estate and risk management, and was also responsible for many of our business development efforts and oversight of several of company key collaborations. He was promoted to President and Chief Operating Officer in June 2016, when he also became responsible for all of company commercial and medical affairs activities.

Basic Compensation

Total Annual Compensation, USD 984,417
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 4,366,740
Fiscal Year Total, USD 5,351,160

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Martine Rothblatt

15,424,300

Michael Benkowitz

5,351,160

Christopher Patusky

528,183

James Edgemond

4,109,450

Paul Mahon

7,628,200

Raymond Dwek

422,782
As Of  30 Dec 2016